| 标题 |
 2O Osimertinib (osi) with or without chemotherapy (CTx) as first-line treatment in EGFR-mutant (EGFRm) advanced NSCLC with concurrent TP53 mutations (TOP study) |
| 网址 | |
| DOI | |
| 其它 |
期刊：ESMO Open 作者：Y. Yang; T. Zhou; F. Gao; W. Feng; W. Jiang; et al 出版日期：2026 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
cdercder
Copyright
俊秀的白曼
Oracle
YifanWang
大力的冬萱
Nole
vtizsty
愉快的真
OK
潇洒的惋清
Criminology34
loii
核桃
sanvva
初景
舒适的如萱
Marciu33
fengfeiyang
皖公网安备34019202002308
